VTVT
vTv Therapeutics Inc
31.90$
+3.3%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +606.8% | -40.5% | -48.8% | -69.3% | +8.3% | +59.6% | +72.2% | +30.5% | -66.9% | +247.3% | +134.9% | |
| – | +5,436.1% | -41.6% | -60.9% | -82.9% | -18.3% | +154.2% | +116.5% | +73.4% | -60.7% | +257.6% | +135.9% | |
| – | +6,258.6% | -41.5% | -77.2% | -85.7% | +5.6% | +223.4% | +133.4% | -9.6% | -22.1% | +289.0% | +142.0% | |
| – | +6,258.6% | -41.5% | -77.2% | -85.7% | +5.6% | +223.4% | +133.4% | -9.6% | -22.1% | +289.0% | +142.0% | |
| – | – | – | – | -100.0% | – | +3,060.0% | -63.9% | +21,682.5% | -99.2% | -39.2% | – | |
| – | – | – | – | – | – | +48.4% | -73.0% | -85.0% | – | – | – | |
| – | -83.5% | -28.8% | -36.3% | -75.3% | +1,334.3% | -63.4% | +85.3% | -69.6% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -66.9% | -14.2% | +23.1% | -48.9% | -80.2% | -39.3% | -6.8% | +167.3% | +7.9% | -18.9% | +6.2% | |
| – | +12.6% | +48.0% | +135.5% | -30.0% | -29.0% | -52.2% | +33.0% | -9.3% | +37.8% | -51.1% | +27.8% | |
| – | +2,071.0% | +148.2% | -48.9% | +119.7% | -33.0% | -96.2% | +84.1% | -14.1% | -4.8% | -53.1% | – | |
| – | +182.2% | +52.0% | -80.1% | +27.8% | -23.0% | -13.8% | -2.5% | +31.2% | +65.6% | -77.0% | +20.6% | |
| – | -100.0% | – | +38.5% | -58.7% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | +428.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +3,886.1% | +15.3% | -97.5% | +28.4% | +143.3% | +55.6% | +32.9% | +22.6% | +8.6% | +176.8% | +46.0% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.